This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2024 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Grant Castor
Senior Vice President, Commercial Strategy & Operations at Sentynl Therapeutics


Grant has over a decade of strategy, finance, and commercial operations experience in the biopharma and medical device industry. Prior to joining our team in 2015, Grant led marketing operations for Amedra Pharmaceuticals and Lineage Therapeutics, which was successfully sold to Impax Laboratories in 2015. Before entering the biopharmaceutical industry Grant held numerous commercial roles in the Medical Device sector; most notably as the head of US operations and global marketing for an Israel-based organization, where they successfully commercialized a novel orthopedic device in over 30 countries. He holds his BS in International Business from Johnson & Wales University.

Agenda Sessions

  • Valuable Insights into Lessons Learned for Launching Rare Disease Products